Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 154

1.

Prospective assessment of lymphedema incidence and lymphedema-associated symptoms following lymph node surgery for melanoma.

Hyngstrom JR, Chiang YJ, Cromwell KD, Ross MI, Xing Y, Mungovan KS, Lee JE, Gershenwald JE, Royal RE, Lucci A, Armer JM, Cormier JN.

Melanoma Res. 2013 Aug;23(4):290-7. doi: 10.1097/CMR.0b013e3283632c83.

2.

The long-term risk of upper-extremity lymphedema is two-fold higher in breast cancer patients than in melanoma patients.

Voss RK, Cromwell KD, Chiang YJ, Armer JM, Ross MI, Lee JE, Gershenwald JE, Stewart BR, Shaitelman SF, Cormier JN.

J Surg Oncol. 2015 Dec;112(8):834-40. doi: 10.1002/jso.24068. Epub 2015 Oct 18.

3.

Prospective assessment of postoperative complications and associated costs following inguinal lymph node dissection (ILND) in melanoma patients.

Chang SB, Askew RL, Xing Y, Weaver S, Gershenwald JE, Lee JE, Royal R, Lucci A, Ross MI, Cormier JN.

Ann Surg Oncol. 2010 Oct;17(10):2764-72. doi: 10.1245/s10434-010-1026-z. Epub 2010 Mar 25.

4.

Defining lower limb lymphedema after inguinal or ilio-inguinal dissection in patients with melanoma using classification and regression tree analysis.

Spillane AJ, Saw RP, Tucker M, Byth K, Thompson JF.

Ann Surg. 2008 Aug;248(2):286-93. doi: 10.1097/SLA.0b013e31817ed7c3.

PMID:
18650640
5.

Obesity is a risk factor for developing postoperative lymphedema in breast cancer patients.

Helyer LK, Varnic M, Le LW, Leong W, McCready D.

Breast J. 2010 Jan-Feb;16(1):48-54. doi: 10.1111/j.1524-4741.2009.00855.x. Epub 2009 Nov 2.

PMID:
19889169
6.

Inguinal node dissection for melanoma in the era of sentinel lymph node biopsy.

Sabel MS, Griffith KA, Arora A, Shargorodsky J, Blazer DG 3rd, Rees R, Wong SL, Cimmino VM, Chang AE.

Surgery. 2007 Jun;141(6):728-35.

PMID:
17560249
7.

[Complication of radical lymph node dissection following sentinel lymph node biopsy in patients with melanoma].

Litrowski N, Duval Modeste AB, Coquerel D, Courville P, Milliez PY, Joly P.

Ann Dermatol Venereol. 2013 Jun-Jul;140(6-7):425-30. doi: 10.1016/j.annder.2013.02.021. Epub 2013 Mar 27. French.

PMID:
23773739
8.

Risk factors associated with lymphedema after lymph node dissection in melanoma patients.

Friedman JF, Sunkara B, Jehnsen JS, Durham A, Johnson T, Cohen MS.

Am J Surg. 2015 Dec;210(6):1178-84; discussion 1184. doi: 10.1016/j.amjsurg.2015.08.014. Epub 2015 Sep 28.

PMID:
26482511
9.

Proactive approach to lymphedema risk reduction: a prospective study.

Fu MR, Axelrod D, Guth AA, Cartwright F, Qiu Z, Goldberg JD, Kim J, Scagliola J, Kleinman R, Haber J.

Ann Surg Oncol. 2014 Oct;21(11):3481-9. doi: 10.1245/s10434-014-3761-z. Epub 2014 May 9.

10.

Residual lymph node disease after neoadjuvant chemotherapy predicts an increased risk of lymphedema in node-positive breast cancer patients.

Specht MC, Miller CL, Skolny MN, Jammallo LS, O'Toole J, Horick N, Isakoff SJ, Smith BL, Taghian AG.

Ann Surg Oncol. 2013 Sep;20(9):2835-41. doi: 10.1245/s10434-012-2828-y. Epub 2013 May 21.

PMID:
23689935
11.

Lymphedema after sentinel lymph node biopsy for cutaneous melanoma: a report of 5 cases.

Wrone DA, Tanabe KK, Cosimi AB, Gadd MA, Souba WW, Sober AJ.

Arch Dermatol. 2000 Apr;136(4):511-4. Review.

PMID:
10768650
12.

The incidence and risk factors for occurrence of arm lymphedema after treatment of breast cancer.

Rebegea L, Firescu D, Dumitru M, Anghel R.

Chirurgia (Bucur). 2015 Jan-Feb;110(1):33-7.

13.

Breast cancer related lymphedema in patients with different loco-regional treatments.

Ozcinar B, Guler SA, Kocaman N, Ozkan M, Gulluoglu BM, Ozmen V.

Breast. 2012 Jun;21(3):361-5. doi: 10.1016/j.breast.2012.03.002. Epub 2012 Mar 27.

PMID:
22460058
14.

Lymphedema following breast cancer treatment, including sentinel lymph node biopsy.

Armer J, Fu MR, Wainstock JM, Zagar E, Jacobs LK.

Lymphology. 2004 Jun;37(2):73-91.

PMID:
15328760
15.

Risk factors associated with breast lymphedema.

Boughey JC, Hoskin TL, Cheville AL, Miller J, Loprinzi MD, Thomsen KM, Maloney S, Baddour LM, Degnim AC.

Ann Surg Oncol. 2014 Apr;21(4):1202-8. doi: 10.1245/s10434-013-3408-5. Epub 2013 Dec 12.

16.

Arm morbidity following sentinel lymph node biopsy or axillary lymph node dissection: a study from the Danish Breast Cancer Cooperative Group.

Husted Madsen A, Haugaard K, Soerensen J, Bokmand S, Friis E, Holtveg H, Peter Garne J, Horby J, Christiansen P.

Breast. 2008 Apr;17(2):138-47. Epub 2007 Oct 24.

PMID:
17928226
17.

Morbidity after inguinal sentinel lymph node biopsy and completion lymph node dissection in patients with cutaneous melanoma.

de Vries M, Vonkeman WG, van Ginkel RJ, Hoekstra HJ.

Eur J Surg Oncol. 2006 Sep;32(7):785-9. Epub 2006 Jun 27.

PMID:
16806794
18.

Morbidity of selective lymph node biopsy for melanoma: meta-analysis of complications.

Cigna E, Gradilone A, Ribuffo D, Gazzaniga P, Fino P, Sorvillo V, Scuderi N.

Tumori. 2012 Jan-Feb;98(1):94-8. doi: 10.1700/1053.11506.

PMID:
22495708
19.

Selective Sentinel Lymph Node Dissection in Lower Extremity Melanoma.

Miranda SG, Parrett BM, Li RR, Lee G, Chang T, Fadaki N, Cardona-Huerta S, Cleaver JE, Kashani-Sabet M, Leong SP.

Plast Reconstr Surg. 2016 Mar;137(3):1031-8. doi: 10.1097/01.prs.0000479990.65243.eb. Erratum in: Plast Reconstr Surg. 2016 Apr;137(4):1357.

PMID:
26809037
20.

Morbidity and recurrence after completion lymph node dissection following sentinel lymph node biopsy in cutaneous malignant melanoma.

Guggenheim MM, Hug U, Jung FJ, Rousson V, Aust MC, Calcagni M, K├╝nzi W, Giovanoli P.

Ann Surg. 2008 Apr;247(4):687-93. doi: 10.1097/SLA.0b013e318161312a.

PMID:
18362633

Supplemental Content

Support Center